中国分子心脏病学杂志2024,Vol.24Issue(3) :6110-6115.DOI:10.16563/j.cnki.1671-6272.2024.06.007

尿毒症患者血清通过ROS-NLRP3信号通路促进人主动脉平滑肌细胞增殖参与新生内膜增生

Uremia Serum Promotes the Proliferation of Human Aortic Smooth Muscle Cells through the ROS-NLRP3 Signaling Pathway and Participates in Neointimal Hyperplasia

段琦 李亚峰 王振峰
中国分子心脏病学杂志2024,Vol.24Issue(3) :6110-6115.DOI:10.16563/j.cnki.1671-6272.2024.06.007

尿毒症患者血清通过ROS-NLRP3信号通路促进人主动脉平滑肌细胞增殖参与新生内膜增生

Uremia Serum Promotes the Proliferation of Human Aortic Smooth Muscle Cells through the ROS-NLRP3 Signaling Pathway and Participates in Neointimal Hyperplasia

段琦 1李亚峰 2王振峰3
扫码查看

作者信息

  • 1. 山西省人民医院肾脏病分子诊断与治疗实验室,太原 030012;山西省人民医院肾脏病山西省重点实验室,太原 030012
  • 2. 山西省人民医院肾脏病山西省重点实验室,太原 030012;山西省人民医院肾内科,太原 030012;山西省人民医院中心实验室,太原 030012;山西医科大学微生态研究院,太原 030012
  • 3. 山西省人民医院血管外科,太原 030012
  • 折叠

摘要

目的 通过在体外模拟慢性肾脏病(chronic kidney disease,CKD)病理环境探讨ROS-NLRP3信号通路在CKD中对血管新生内膜增生的影响.方法 体外培养人主动脉平滑肌细胞(human aortic smooth muscle cells,HASMCs),实验分为3组:正常血清对照组(NC组)、尿毒症血清处理组(CKD组)、尿毒症血清+Mito-TEMPO处理组(CKD+Mito-TEMPO组).采用Western blot、免疫荧光和ELISA实验方法观察尿毒症血清对HASMCs表型、氧化应激水平、炎症因子表达水平以及NLRP3炎症复合体表达的影响.结果 与NC组相比,经尿毒症患者血清处理后,HASMCs增殖显著增强,平滑肌肌动蛋白α(smooth muscle actin α,α-SMA)和钙调理蛋白1的蛋白表达、线粒体活性氧(mitochondrial reactive oxygen species,mtROS)水平显著增加(P均<0.05),炎症因子白细胞介素-6(interleukin-6,IL-6)、IL-18和TNF-α的水平显著增加(P均<0.05),nod样受体蛋白 3(nod-like receptor protein 3,NLRP3)、半胱氨酸天冬氨酸蛋白水解酶-1(cysteinyl aspartate specific proteinase-1,caspase-1)、剪切的caspase-1、1L-1β和IL-18的蛋白表达水平显著增加(P均<0.05),超氧化物歧化酶(superoxide dismutase,SOD)活性降低显著降低(P<0.05);而加入mtROS抑制剂后,HASMCs增殖显著降低;α-SMA和钙调理蛋白1的蛋白表达,mtROS水平,炎症因子IL-6、IL-18、TNF-α水平,NLRP3、caspase-1、剪切的caspase-l、IL-1 β和IL-18蛋白表达水平均显著减少(P均<0.05);SOD活性降低显著增加(P<0.05).结论 尿毒症血清通过ROS-NLRP3信号通路促进HASMCs增殖、参与新生内膜增生.

Abstract

Objective To explore the effect of ROS-NLRP3 signaling pathway on neointimal hyperplasia(NH)induced by chronic kidney disease(CKD)in vitro.Methods Human aortic smooth muscle cells(HASMCs)were cultured and divided into three groups:normal serum control(NC)group,uremia serum treatment group,uremia serum+Mito-TEMPO treatment group.The effects of uremia serum on HASMCs phenotype,oxidative stress level,expression levels of inflammatory factors and non-like receptor protein 3(NLRP3)inflammatory complex were detected by Western blot,immunofluorescence and ELISA assays.Results Compared to NC group,the proliferation of HASMCs,the protein expressions of α-SMA and calponin 1,the levels of mitochondrial reactive oxygen species(mtROS),and inflammatory factor IL-6,IL-18 and TNF-α,protein expressions of NLRP3,cysteinyl aspartate specific proteinase-1(caspase-1),cleaved caspase-1,IL-1β,and IL-18 were significantly increased(all P<0.05),superoxide dismutase(SOD)activity was significantly decreased(all P<0.05)after treatment of uremia serum.However,the proliferation of HASMCs,the protein expressions of α-SMA and calponin 1,levels of mtROS,inflammatory factor IL-6,IL-18 and TNF-α,and the protein expression levels of NLRP3,caspase-1,cleaved caspase-1,IL-1β,and IL-18 were significantly decreased(all P<0.05),SOD activity was significantly increased(P<0.05)in uremia serum+Mito-TEMPO treatment group.Conclusion Uremia serum can promote the proliferation of HASMCs in neointimal hyperplasia through ROS-NLRP3 signaling pathway.

关键词

尿毒症/新生内膜增生/线粒体活性氧/人主动脉平滑肌细胞/NLRP3

Key words

Uremia/Neointimal hyperplasia/Mitochondrial reactive oxygen species/Human aortic smooth muscle cells/Nod-like receptor protein 3

引用本文复制引用

基金项目

山西省自然科学基金面上自然基金项目(201901D111439)

山西省基础研究自由探索类青年科学研究项目(20210302124303)

出版年

2024
中国分子心脏病学杂志
中国医学科学院,中国协和医学院

中国分子心脏病学杂志

CSTPCD
影响因子:0.426
ISSN:1671-6272
参考文献量3
段落导航相关论文